ProGenis Pharmaceuticals is a biotechnology firm specializing in precision RNA medicines.
ProGenis Pharmaceuticals has raised $65K in total funding. The most recent round was Grant. The last funding was announced in November 2025.
ProGenis Pharmaceuticals's investors include MTPConnect, Future Health Research and Innovation.
ProGenis Pharmaceuticals is headquartered in Bentley, Australia.
ProGenis Pharmaceuticals is a biotechnology firm specializing in precision RNA medicines.
ProGenis Pharmaceuticals is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ProGenis Pharmaceuticals — Funding & Investors." VCBacked, November 19, 2025, https://www.vcbacked.co/company/progenis-pharmaceuticals. Accessed August 17, 2026.
VCBacked. (2025). ProGenis Pharmaceuticals — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/progenis-pharmaceuticals
{{cite web |title=ProGenis Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/progenis-pharmaceuticals |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated